Press release
Post Menopausal Osteoporosis Market is expected to reach US$ 15.2 billion by 2031 growing with a CAGR of 5.4% | Pfizer Inc., Amgen Inc., Novartis AG, AbbVie Inc.
The Global Post Menopausal Osteoporosis Market reached US$ 9.9 billion in 2023 and is expected to reach US$ 15.2 billion by 2031 growing with a CAGR of 5.4% during the forecast period 2024-2031.Post Menopausal Osteoporosis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/post-menopausal-osteoporosis-market?rk
Post-menopausal osteoporosis is a bone condition that occurs after menopause, characterized by reduced bone density and increased fracture risk. This condition arises from declining estrogen levels, which affect bone remodeling. Treatment includes calcium and vitamin D supplements, lifestyle changes, and medications like bisphosphonates. Regular weight-bearing exercises and bone density screenings help prevent severe bone loss. Early intervention minimizes fracture risks and improves bone health.
List of the Key Players in the Post Menopausal Osteoporosis Market:
Sandoz Group AG, Pfizer Inc., Amgen Inc., Novartis AG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Merck & Co., Inc., Ambio Inc., and GSK plc.
Industry Development:
In July 2024, Romosozumab, a humanized monoclonal antibody that inhibits sclerostin, received FDA approval for treating osteoporosis in postmenopausal women at high risk of fractures. This anabolic therapy enhances bone formation while reducing bone resorption, effectively increasing bone mineral density and lowering fracture risk associated with osteoporosis.
Growth Forecast Projected:
The Global Post Menopausal Osteoporosis Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Post Menopausal Osteoporosis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/post-menopausal-osteoporosis-market?rk
Segment Covered in the Post Menopausal Osteoporosis Market:
By Drug Class: Bisphosphonates, RANK Ligand Inhibitors (Denosumab), Selective Estrogen Receptor Modulator (SERM) (Raloxifene), Monoclonal Antibody (Romosozumab), Parathyroid Hormone Analog, Calcitonin, Strontium, Anti-Sclerostin, Cathepsin K Inhibitors (CatK), Others.
By Route of Administration: Oral, Parenteral, Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Regional Analysis for Post Menopausal Osteoporosis Market:
The regional analysis of the Post Menopausal Osteoporosis Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/post-menopausal-osteoporosis-market?rk
People Also Ask:
➠ What is the global sales, production, consumption, import, and export value of the Post Menopausal Osteoporosis market?
➠ Who are the leading manufacturers in the global Post Menopausal Osteoporosis industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?
➠ What opportunities and challenges do vendors in the global Post Menopausal Osteoporosis industry face?
➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?
➠ What are the key factors and limitations affecting the growth of the Post Menopausal Osteoporosis market?
➠ What are the various sales, marketing, and distribution channels in the global industry?
Browse More Reports: https://www.datamintelligence.com/research-report/post-menopausal-osteoporosis-market?rk
Osteoporosis Testing Market: https://www.datamintelligence.com/download-sample/osteoporosis-testing-market?rk
Osteoporosis Drugs Market: https://www.datamintelligence.com/download-sample/osteoporosis-drugs-market?rk
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Post Menopausal Osteoporosis Market is expected to reach US$ 15.2 billion by 2031 growing with a CAGR of 5.4% | Pfizer Inc., Amgen Inc., Novartis AG, AbbVie Inc. here
News-ID: 3909006 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Hydrotreating Catalysts Market to Reach USD 1.74 Billion by 2031, …
Global Hydrotreating Catalysts Market reached US$ 1,284.2 million in 2023 and is expected to reach US$ 1,735.5 million by 2031, growing with a CAGR of 4.0% during the forecast period 2024-2031.
Hydrotreating Catalysts Market involves catalysts used in refining petroleum to remove sulfur, nitrogen, and impurities. Growth is driven by fuel quality regulations, refinery upgrades, and cleaner fuel demand. Catalysts improve efficiency, yield, and environmental compliance. Refineries and chemical plants are…
United States Biocontrol Agents Market to Reach USD 11.37 Billion by 2031, Growi …
Global Biocontrol Agents Market reached US$ 6.10 billion in 2022 and is expected to reach US$ 11.37 billion by 2031, growing with a CAGR of 8.1% during the forecast period 2024-2031.
The Biocontrol Agents Market includes microorganisms, viruses, or natural compounds that control agricultural pests and diseases. Growth is driven by sustainable farming, organic agriculture, and reduced chemical pesticide use. Applications include crop protection for fruits, vegetables, and grains. Farmers, agritech…
United States Polyurethane Tape Market: Rising Demand for Durable, Flexible, and …
Global Polyurethane Tape Market reached US$ 1.9 billion in 2023 and is expected to reach US$ 2.7 billion by 2031, growing with a CAGR of 4.4% during the forecast period 2024-2031.
Polyurethane Tape Market includes flexible adhesive tapes used in electronics, automotive, construction, and medical applications. Growth is driven by high durability, chemical resistance, and flexibility requirements. Applications include insulation, bonding, and protective coating. Manufacturers, construction companies, and electronics OEMs are…
Japan Cell Therapy Market to Reach US$ 1.63 Billion by 2033, Driven by Rapid Bio …
Japan Cell Therapy Market reached US$ 416.83 Million in 2024 and is expected to reach US$ 1,632.99 Million by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033.
Japan's Cell Therapy Market focuses on regenerative treatments using stem cells and specialized cell-based therapies. Growth is driven by aging populations, chronic diseases, and government-backed regenerative medicine initiatives. Applications include oncology, orthopedic, and cardiovascular therapies. Hospitals, research institutes, and biotech…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
